Today: 17 May 2026
Browse Category

ASX:CAR 13 December 2025 - 2 March 2026

CAR Group (ASX:CAR) share price slips after close as RBA rate path and March dividend come into focus

CAR Group (ASX:CAR) share price slips after close as RBA rate path and March dividend come into focus

CAR Group shares fell 0.54% to A$25.61 at Tuesday’s close, reversing part of Monday’s gain, as the RBA minutes signaled no clear rate path and markets priced a possible May hike. The company’s next key date is March 13, when shares go ex-dividend for a 42.5-cent interim payout. The S&P/ASX 200 index rose 0.24%. CAR’s half-year report showed 8% revenue growth and a 16% rise in net profit.
17 February 2026
···

Stock Market Today

  • Meta Platforms Stock Quote Price and Forecast
    May 16, 2026, 10:17 PM EDT. Meta Platforms, Inc. develops major social media applications including Facebook and Instagram through its Family of Apps segment, and invests in augmented and virtual reality via Reality Labs. Founded in 2004 by Mark Zuckerberg and co-founders, the Menlo Park-based company drives connectivity and business growth through technology. Meta's stock reflects its dual focus on social media dominance and emerging reality technologies, impacting market forecasts and investment outlooks.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Go toTop